Free Trial

Cardinal Health (CAH) Competitors

Cardinal Health logo
$118.28 +1.28 (+1.09%)
(As of 12/20/2024 05:31 PM ET)

CAH vs. MCK, COR, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS

Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include McKesson (MCK), Cencora (COR), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).

Cardinal Health vs.

Cardinal Health (NYSE:CAH) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation.

Cardinal Health has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.

McKesson has higher revenue and earnings than Cardinal Health. Cardinal Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$224.45B0.13$852M$5.1423.01
McKesson$330.19B0.22$3.00B$19.3130.02

McKesson has a net margin of 0.77% compared to Cardinal Health's net margin of 0.56%. Cardinal Health's return on equity of -56.56% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.56% -56.56% 4.13%
McKesson 0.77%-207.50%5.45%

McKesson received 51 more outperform votes than Cardinal Health when rated by MarketBeat users. Likewise, 74.23% of users gave McKesson an outperform vote while only 71.64% of users gave Cardinal Health an outperform vote.

CompanyUnderperformOutperform
Cardinal HealthOutperform Votes
917
71.64%
Underperform Votes
363
28.36%
McKessonOutperform Votes
968
74.23%
Underperform Votes
336
25.77%

In the previous week, Cardinal Health had 6 more articles in the media than McKesson. MarketBeat recorded 18 mentions for Cardinal Health and 12 mentions for McKesson. Cardinal Health's average media sentiment score of 0.93 beat McKesson's score of 0.90 indicating that Cardinal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
9 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
McKesson
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cardinal Health currently has a consensus price target of $127.50, indicating a potential upside of 7.80%. McKesson has a consensus price target of $650.14, indicating a potential upside of 12.14%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
McKesson
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.94

Cardinal Health pays an annual dividend of $2.02 per share and has a dividend yield of 1.7%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cardinal Health pays out 39.3% of its earnings in the form of a dividend. McKesson pays out 14.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years.

Summary

McKesson beats Cardinal Health on 16 of the 22 factors compared between the two stocks.

Get Cardinal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$28.62B$19.76B$5.12B$19.18B
Dividend Yield1.75%1.47%4.91%3.59%
P/E Ratio23.0110.7691.3441.28
Price / Sales0.138.901,116.5917.59
Price / Cash11.1512.2742.6421.28
Price / Book-8.9713.334.795.32
Net Income$852M$862.89M$120.07M$989.88M
7 Day Performance0.15%-6.95%-1.89%-3.54%
1 Month Performance-4.07%-10.66%11.45%-3.68%
1 Year Performance16.85%-6.09%30.61%12.14%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAH
Cardinal Health
4.7219 of 5 stars
$118.28
+1.1%
$127.50
+7.8%
+19.3%$28.62B$224.45B23.0148,900Analyst Forecast
High Trading Volume
MCK
McKesson
4.9558 of 5 stars
$575.01
-0.2%
$643.43
+11.9%
+30.0%$72.99B$330.19B29.8451,000Analyst Forecast
COR
Cencora
4.7201 of 5 stars
$230.94
-0.6%
$275.60
+19.3%
+14.0%$44.64B$638.56M30.9246,000
HSIC
Henry Schein
3.9527 of 5 stars
$76.42
-0.2%
$78.89
+3.2%
-4.9%$9.53B$12.34B31.5225,000
PDCO
Patterson Companies
4.1391 of 5 stars
$31.02
-0.2%
$26.24
-15.4%
+11.0%$2.74B$6.57B18.187,600Analyst Forecast
OMI
Owens & Minor
4.5636 of 5 stars
$13.71
-1.6%
$18.50
+34.9%
-38.1%$1.06B$10.33B0.0013,700Positive News
HLF
Herbalife
4.6776 of 5 stars
$7.23
-3.3%
$9.90
+36.9%
-56.6%$728.73M$5.00B8.669,200
NUS
Nu Skin Enterprises
3.55 of 5 stars
$7.33
-2.1%
$8.88
+21.1%
-65.8%$364.38M$1.78B-3.593,700Analyst Forecast
Analyst Revision
Gap Down
COSM
Cosmos Health
0.3524 of 5 stars
$0.70
-3.0%
N/A-54.5%$16.28M$53.38M-0.29123Gap Up
HWH
HWH International
N/A$0.56
-16.6%
N/AN/A$15.06MN/A0.00N/ANews Coverage
Gap Up
MEDS
TRxADE HEALTH
N/A$7.47
-4.5%
N/A+54.9%$10.50M$7.45M0.0050Gap Down

Related Companies and Tools


This page (NYSE:CAH) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners